1-3 of 3
Seema Kantak, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HCD122, an Antagonist Human Anti-CD40 Monoclonal Antibody, Enhances Efficacy of CHOP in Tumor Xenograft Model of Human Diffuse Large B-Cell Lymphoma.

Mohammad Luqman, PhD, Ssucheng J. Hsu, Ph.D., Matthew Ericson, Sha Klabunde, M.D., Seema Kantak, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 528.
https://doi.org/10.1182/blood.V110.11.528.528
Published: 2007
Journal Articles

Efficacy of an Antagonistic Anti-CD40 Monoclonal Antibody, HCD122 (CHIR-12.12), in Preclinical Models of Human Non-Hodgkin’s Lymphoma and Hodgkin’s Disease.

Li Long, PhD, Montesa Patawaran, B.Sc., Xia Tong, M.Sc., Seema Kantak, Ph.D., Sharon L. Aukerman, Ph.D., Nancy Pryer, Ph.D., Mohammad Luqman, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 230.
https://doi.org/10.1182/blood.V108.11.230.230
Published: 2006
Journal Articles

HCD122, an Antagonist Human Anti-CD40 Monoclonal Antibody, Inhibits Tumor Growth in Xenograft Models of Human Diffuse Large B-Cell Lymphoma, a Subset of Non-Hodgkins Lymphoma.

Ssucheng J. Hsu, PhD, Lin A. Esposito, B.S., Sharon L. Aukerman, Ph.D., Seema Kantak, Ph.D., Amer M. Mirza, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2519.
https://doi.org/10.1182/blood.V108.11.2519.2519
Published: 2006